- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Elutia
Market Cap: US$70.3m
A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.
ELUT
US$1.81
7D
-0.5%
1Y
-46.1%
TScan Therapeutics
Market Cap: US$70.2m
A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.
TCRX
US$1.24
7D
-9.5%
1Y
-86.5%
Milestone Scientific
Market Cap: US$70.1m
A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.
MLSS
US$1.02
7D
10.2%
1Y
42.7%
Optiscan Imaging
Market Cap: AU$108.6m
Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States.
OIL
AU$0.13
7D
18.2%
1Y
32.7%
Zura Bio
Market Cap: US$68.7m
A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.
ZURA
US$1.08
7D
-12.9%
1Y
-82.0%
Alto Neuroscience
Market Cap: US$68.5m
Operates as a clinical-stage biopharmaceutical company in the United States.
ANRO
US$2.54
7D
8.5%
1Y
-79.5%
Adlai Nortye
Market Cap: US$68.3m
A clinical-stage biotechnology company, engages in the research and development of pharmaceutical products.
ANL
US$1.86
7D
-1.6%
1Y
-85.4%
Austco Healthcare
Market Cap: AU$105.6m
Operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America.
AHC
AU$0.29
7D
1.8%
1Y
54.7%
Clearside Biomedical
Market Cap: US$67.9m
A biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.
CLSD
US$0.89
7D
-0.2%
1Y
-33.2%
Medicenna Therapeutics
Market Cap: CA$94.2m
An immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.
MDNA
CA$1.13
7D
0%
1Y
-50.2%
vTv Therapeutics
Market Cap: US$67.1m
A clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases.
VTVT
US$21.25
7D
-1.0%
1Y
-24.7%
Forian
Market Cap: US$67.1m
Provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.
FORA
US$2.20
7D
10.6%
1Y
-17.6%
BeyondSpring
Market Cap: US$66.9m
A clinical stage biopharmaceutical company, focuses on the development of cancer therapies.
BYSI
US$1.67
7D
1.2%
1Y
-36.5%
EDX Medical Group
Market Cap: UK£49.3m
Engages in developing a range of diagnostics testing solutions in the United Kingdom.
EDX
UK£0.15
7D
34.1%
1Y
96.7%
EDAP TMS
Market Cap: US$65.8m
Develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.
EDAP
US$1.86
7D
-13.5%
1Y
-70.1%
Kooth
Market Cap: UK£49.2m
Provides digital mental health services to children, young people, and adults in the United Kingdom.
KOO
UK£1.38
7D
9.6%
1Y
-54.5%
Seres Therapeutics
Market Cap: US$65.1m
A clinical-stage company, focuses on developing biotherapeutics for serious diseases.
MCRB
US$7.98
7D
1.3%
1Y
-58.0%
Kalaris Therapeutics
Market Cap: US$65.1m
A clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.
KLRS
US$3.25
7D
-3.8%
1Y
n/a
Acumen Pharmaceuticals
Market Cap: US$64.8m
A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.
ABOS
US$1.07
7D
1.9%
1Y
-72.1%
Vitrafy Life Sciences
Market Cap: AU$100.6m
Provides cryopreservation solutions in Australia.
VFY
AU$1.58
7D
-7.1%
1Y
n/a
MediciNova
Market Cap: US$64.7m
A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
MNOV
US$1.40
7D
-2.8%
1Y
2.2%
Citius Oncology
Market Cap: US$64.7m
Focuses on the development of novel targeted oncology therapies.
CTOR
US$0.91
7D
1.9%
1Y
-91.9%
IO Biotech
Market Cap: US$64.6m
A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.
IOBT
US$1.04
7D
1.0%
1Y
-24.6%
PDS Biotechnology
Market Cap: US$64.5m
A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.
PDSB
US$1.46
7D
13.2%
1Y
-56.8%
SDI
Market Cap: AU$99.8m
Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.
SDI
AU$0.84
7D
0%
1Y
5.7%
Adicet Bio
Market Cap: US$64.3m
A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.
ACET
US$0.71
7D
-2.1%
1Y
-56.4%
Vita Life Sciences
Market Cap: AU$99.4m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$1.80
7D
-2.2%
1Y
-17.1%
Context Therapeutics
Market Cap: US$63.9m
A biopharmaceutical company, develops products for the treatment of solid tumors.
CNTX
US$0.71
7D
-9.4%
1Y
-64.5%
Assertio Holdings
Market Cap: US$63.8m
A pharmaceutical company, provides various products to patients in the United States.
ASRT
US$0.71
7D
15.5%
1Y
-31.6%
Exicure
Market Cap: US$63.6m
Does not have significant operations.
XCUR
US$10.23
7D
-13.7%
1Y
330.6%
enVVeno Medical
Market Cap: US$63.5m
A clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease.
NVNO
US$3.63
7D
0.6%
1Y
-27.4%
BioSig Technologies
Market Cap: US$63.3m
A medical technology company, provides digital signal processing technology platform services in the United States.
BSGM
US$2.85
7D
30.5%
1Y
60.7%
Jushi Holdings
Market Cap: US$63.1m
A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.
JUSH.F
US$0.37
7D
5.2%
1Y
-44.5%
Nutriband
Market Cap: US$62.5m
Develops a portfolio of transdermal pharmaceutical products.
NTRB
US$5.71
7D
-2.1%
1Y
17.7%
Medexus Pharmaceuticals
Market Cap: CA$86.8m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.69
7D
-1.5%
1Y
68.1%
Metagenomi
Market Cap: US$62.1m
A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.
MGX
US$1.71
7D
10.3%
1Y
-74.4%